Durable Response to Pazopanib in a Patient with Fumarate Hydratase-Mutant Tubulocystic Renal Cell Carcinoma

Tubulocystic carcinoma of the kidney (TC-RCC) is a rare renal tumor and has been recently included as a distinct entity in WHO classification of renal neoplasms. We report the case of a patient with metastatic tubulocystic RCC whose disease progressed through standard of care treatment for nonclear...

Full description

Bibliographic Details

Published in:	Case Reports in Oncology
Main Authors:	Anjum Othman, Shiyam Kumar, Asim Qureshi, Zabah M. Jawa, Ikram A. Burney
Format:	Article
Language:	English
Published:	Karger Publishers 2023-04-01
Subjects:	renal cell carcinoma tubulocystic genomic profiling precision oncology fumarate hydrogenase pazopanib
Online Access:	https://www.karger.com/Article/FullText/528697